Skip to content

Investigating the role of dobutamine in reducing fluid accumulation

Investigating the role of low dose dobutamine in reducing fluid accumulation , a randomized clinical trial

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
IRCT
Registry ID
IRCT20251209068261N1
Enrollment
10
Registered
2025-12-24
Start date
2026-01-21
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sepsis. Other sepsis

Interventions

Intervention 1: Control group: Control group: A group of patients admitted to the intensive care unit who will be randomly selected. This group will be candidates for receiving only routine and standa

Sponsors

Rasht University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Clear detection of fluid accumulation of 10%of body weight Electrolyte levels and kidney function should be within normal or acceptable ranges Filling out the informed consent form

Exclusion criteria

Exclusion criteria: Presence of severe underlying diseases Patients with severe acute or chronic illnesses Severe rhythms or drug sensitivity contraindications

Design outcomes

Primary

MeasureTime frame
Systemic complications. Timepoint: Daily. Method of measurement: Measurement of body temperature, pulse rate per minute, respiratory rate per minute and blood pressure.

Secondary

MeasureTime frame
Hospital stay. Timepoint: At the beginning of treatment and 48 hours after injection. Method of measurement: It is recorded based on patient records.;Mortality. Timepoint: At the beginning of treatment and 48 hours after injection. Method of measurement: It is recorded based on patient records.;Examination of biochemical indicators. Timepoint: At the beginning of treatment and 48 hours after injection. Method of measurement: It is recorded based on patient records.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr.Anoush Dehnadi Moghadam

Rasht University of Medical Sciences

dehnadi@gtrc.ir+98 13 1323 8373

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 7, 2026